New study shows severe toxicity with high-dose AAV9-based gene therapy in animal models

January 30, 2018, Mary Ann Liebert, Inc
Credit: Mary Ann Liebert, Inc., publishers

Researchers have described severe, life-threatening toxicity in monkeys and piglets given high doses of gene therapy delivered using an adeno-associated virus (AAV9) vector capable of accessing spinal cord neurons. The liver and neuronal toxicity reported here are different than the immune-related toxicity described with other AAV vectors, as reported in an article published Human Gene Therapy.

James M. Wilson, MD, PhD and coauthors from the University of Pennsylvania Perelman School of Medicine, Philadelphia, evaluated the ability of an AAV9 variant (AAVhu68) to deliver a human gene to motor neurons in the spinal cords of young rhesus macaques and pigs. AAV9 is the same viral vector recently used successfully to deliver a therapeutic gene to infants with spinal muscular atrophy (SMA). High-dose intravenous administration led to severe affecting the liver and , with symptoms appearing within 5 days of treatment. The researchers reported their findings in the article entitled "Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an AAV Vector Expressing Human SMN."

Human Gene Therapy Editor-in-Chief Terence R. Flotte and Editor of Human Gene Therapy Methods Hildegard Büning urged the gene therapy community to interpret and respond to these findings "in a balanced and responsible fashion," neither ignoring them nor over-reacting, in their Editorial entitled "Severe Toxicity in Non-Human Primates and Piglets with Systemic High-Dose Administration of AAV9-Like Vectors: Putting Patients First." The editors point out the important limitations of the current study and suggest "that the one and only guiding principle in critical moments like this should be the welfare of patients with the diseases being treated with these therapies."

"We advocate for full transparency with all relevant safety data from all laboratories, whether within academia, industry and government. While not all sources of vector are of equivalent quality and purity, the true properties of possible AAV9(-like) vector toxicities will inevitably be best illuminated by multiple different studies being performed by multiple independent groups. This is not a time to protect proprietary interests or academic rivalries. We assert this not out of naïveté, but rather based on our conviction that if the gene research community makes patient welfare as the sole priority, it will ultimately be beneficial to us all," says Editor-in-Chief Terence R. Flotte, MD, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Medical School, Worcester, MA.

Explore further: New gene delivery approach could allow long-term persistence in proliferating cells

More information: Christian Hinderer et al, Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an AAV vector expressing human SMN, Human Gene Therapy (2018). DOI: 10.1089/hum.2018.015

Related Stories

New gene delivery approach could allow long-term persistence in proliferating cells

September 22, 2017
Researchers added a scaffold/matrix attachment region (S/MAR) to a conventional adeno-associated virus (AAV) vector used for gene transfer, and the modified vectors were able to establish colonies and maintain long-term transgene ...

Researchers improve vbectors for delivering hFVIII gene therapy to treat Hemophilia A

March 31, 2017
A new study examined 42 combinations of promoters and enhancers for human factor VIII (hFVIII) gene expression to identify the optimal adeno-associated virus (AAV)-based gene therapy delivery vector constructs to take forward ...

Gene therapy for liver disease advancing with the help of adeno-associated viral vectors

December 30, 2016
Liver-directed gene therapy delivered using adeno-associated viral (AAV) vectors to treat diseases such as hemophilia have advanced into human testing. The potential for continued technological improvements to expand the ...

Gene delivery of drugs directly into arthritic joints is making the leap to patients

January 22, 2018
Localized gene delivery to diseased joints to achieve sustained drug production at the site of osteoarthritis or rheumatoid arthritis is gaining momentum, with clinical trials underway in the U.S. and the first arthritis ...

Gene therapy to prevent vision loss: Studies in primates needed to optimize human trials

December 29, 2016
Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss, and much can be learned about the safety and effectiveness of these promising new therapies by studying ...

What causes gene transfer to trigger T cell activation and exhaustion?

April 27, 2017
Researchers are beginning to gain a clearer understanding of how the immune system responds, in both a reactive and tolerant way, to gene therapy delivered using what has become the preferred gene delivery vector, adeno-associated ...

Recommended for you

The puzzle of a mutated gene lurking behind many Parkinson's cases

November 15, 2018
Genetic mutations affecting a single gene play an outsized role in Parkinson's disease. The mutations are generally responsible for the mass die-off of a set of dopamine-secreting, or dopaminergic, nerve cells in the brain ...

Gene mutation found to cause macrocephaly and intellectual deficits

November 13, 2018
The absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder, according to new research that builds on decades of work by a University at Buffalo biochemist and his colleagues.

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

Decrease in specific gene 'silencing' molecules linked with pediatric brain tumors

November 12, 2018
Experimenting with lab-grown brain cancer cells, Johns Hopkins Medicine researchers have added to evidence that a shortage of specific tiny molecules that silence certain genes is linked to the development and growth of pediatric ...

Recessive genes explain only small fraction of undiagnosed developmental disorders

November 8, 2018
The Deciphering Developmental Disorders study has discovered that only a small fraction of rare, undiagnosed developmental disorders in the British Isles are caused by recessive genes. The study by researchers from the Wellcome ...

A look at how colds and chronic disease affect DNA expression

November 8, 2018
We're all born with a DNA sequence that encodes (in the form of genes) the very traits that make us, us—eye color, height, and even personality. We think of those genes as unchanging, but in reality, the way they are expressed, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.